
ARCHIVES
2010 – Understanding the Interface Between Asthma, Host Defense and Mucosal Immunity

At this pioneering University of Pittsburgh Asthma Institute-hosted conference, foremost experts presented the latest understanding of biological pathways in asthma and clinical innovations for improving patient outcomes.
Following all speaker sessions on the first day, a facilitated poster session was led by Lauren Cohn, MD, Yale University for researchers to present their findings.
The first day concluded with an evening banquet featuring a presentation by Jeffrey M. Drazen, MD, Harvard Medical School and editor-in-chief of The New England Journal of Medicine.
Scientific Sessions:
This revolutionary conference of international experts, caregivers, and industry specialists was a unique opportunity to discuss emerging data about asthma and analyze the information in relation to daily clinical practice and decision-making.
Day 1 of the two-day event focused on genetic, environmental, and phenotypic features that influence clinical care of several airway diseases.
- Non-Asthmatic Airway Disease: Clinical Update
- Asthma Phenotypes: Implications for Disease Mechanisms and Therapy
- Linking the Phenome to the Genome to Identify Endotypes
The second day focused on host, pathogen, and immune responses in asthma.
- The Intersection of Pathogens and Asthma: From Allergic Sensitization to Phenotyping
- First Lines of Host Defense: The Conversion of Innate with Adaptive Responses
- Th17: Too Much, Too Little (Or Too Late)?
- T Regulatory Cells in Many Flavors and Their Role in Allergic Inflammation
- Leading Thinkers from Industry
Distinguished speakers included:
- Kathleen C. Barnes, PhD | Johns Hopkins University
- Eugene R. Bleeker, MD | Wake Forest University School of Medicine
- Jessica M. Bon, MD | University of Pittsburgh School of Medicine
- William Busse, MD | University of Wisconsin
- Juan C. Celedón, DrPH, MD | Children’s Hospital of Pittsburgh
- Sheldon Cohen, PhD | Carnegie Mellon University
- Chen Dong, PhD | University of Texas, MD Anderson Cancer Center
- Jack A. Elias, MD | Yale University
- Christopher N. Faber, MD | University of Pittsburgh School of Medicine
- Kenneth E. Fasanella, MD | University of Pittsburgh School of Medicine
- Stephen J. Galli, MD | Stanford University School of Medicine
- Kevin F. Gibson, MD | University of Pittsburgh School of Medicine
- Fernando Holguin, MD, MPH | University of Pittsburgh School of Medicine
- Jay K. Kolls, MD |Louisiana State University
- Mark Larché, PhD | McMaster University
- Robert F. Lemanske, Jr., MD | University of Wisconsin School of Medicine
- R. Stokes Peebles, MD | Vanderbilt University
- Andrej A. Petrov, MD | University of Pittsburgh School of Medicine
- Anuradha Ray, PhD | University of Pittsburgh School of Medicine
- Prabir Ray, PhD | University of Pittsburgh School of Medicine
- Clark A. Rosen, MD | University of Pittsburgh School of Medicine
- Robert P. Schleimer, PhD | Northwestern University
- David A. Schwartz, MD, MPH | National Jewish Health
- Frank C. Sciurba, MD | University of Pittsburgh School of Medicine
- Donata Vercelli, MD | University of Arizona
- Erika von Mutius, MD, MSc | Ludwig-Maximilians- Universität, Munich
- Sally E. Wenzel, MD | University of Pittsburgh School of Medicine
- Marsha Wills-Karp, PhD | University of Cincinnati College of Medicine
- Prescott G. Woodruff, MD, MPH | University of California, San Francisco